Other GLP-1 medications remain under patent: Eli Lilly's medications (Mounjaro and Zepbound): Tirzepatide works differently from semaglutide, targeting both GLP-1 and GIP receptors rather than GLP-1 alone
doi: 10.1158/1078-0432.CCR-12-0041 14 PfeifferTSchusterSBonhoefferS
However, the standard practice and guideline-default position is that Z79.4 is not required for E10 patients
It is a hormone-friendly, non-aggressive way to achieve firming results
Be ready to discuss your nutrition, activity level, sleep, stress, and lifestyle habits
Sleep deprivation, chronic stress, and sedentary behavior all increase cortisol and ghrelin (the hunger hormone), working against semaglutide's mechanism